Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
Open Access
- 30 September 2024
- journal article
- review article
- Published by Elsevier in Frontiers in Neuroendocrinology
- Vol. 75, 101156
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 100 references indexed in Scilit:
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and SuicideJAMA Network Open, 2022
- Diagnosis and Treatment of Parkinson DiseaseJAMA, 2020
- Projection of the prevalence of Parkinson's disease in the coming decades: RevisitedMovement Disorders, 2017
- In vivo gastric detection of α‐synuclein inclusions in Parkinson's diseaseMovement Disorders, 2014
- Projected numbers of people with movement disorders in the years 2030 and 2050Movement Disorders, 2011
- A preliminary study of finasteride in Tourette syndromeMovement Disorders, 2011
- Neuroactive steroids: State of the art and new perspectivesCellular and Molecular Life Sciences, 2007
- Gender and the Parkinson’s disease phenotypeJournal of Neurology, 2005
- Systematic review of incidence studies of Parkinson's diseaseMovement Disorders, 2002
- Letters to the EditorMovement Disorders, 1998